US Patent 8389689 Anti-GLP-1R antibodies and their uses

Patent 8389689 was granted and assigned to Janssen Biotech on March, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8389689

Date of Patent

March 5, 2013

Patent Application Number

12913406

Date Filed

October 27, 2010

Patent Citations Received

‌

US Patent 11884736 Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)

‌

US Patent 12090193 Glucagon-like peptide 1 receptor agonists and uses thereof

‌

US Patent 11779633 Glucagon-like peptide 1 receptor agonists and uses thereof

Patent Primary Examiner

‌

Ruixiang Li

Patent abstract

The present invention relates to antibodies reactive with GLP-1R, and methods of making and using them.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8389689 Anti-GLP-1R antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API